Department of Gastroenterology, Qilu Hospital, Shandong University
Jinan, Shandong, 250012, China
NCT Number: NCT01024621
The purpose of this study is to assess whether confocal laser endomicroscopy can reduce the biopsy number needed per patient for the detection of gastric intestinal metaplasia without the loss of corresponding diagnostic yield.
Looking for future studies?
Notify Me40 year–80 year
All sexes
Interventional
Not applicable
Jinan, Shandong, 250012, China
Gastric intestinal metaplasia is a well-known premalignant lesions for intestinal type gastric cancer. However, present guidelines such as the updated Sydney System require multiple biopsies whereas reveal an unsatisfactory yield considering the detection and surveillance of these lesions. Confocal laser endomicroscopy is a newly developed endoscopic device that enables microscopic view of the digestive tract. Previous study has showed high sensitivity and specificity for in vivo diagnosis of gastric intestinal metaplasia using confocal laser endomicroscopy. This study aims to assess the real number of biopsies that can be reduced for the detection of gastric intestinal metaplasia using confocal laser endomicroscopy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pentax EC3870K, Tokyo, Japan
Other names: Pentax EC3870K endomicroscope
Pentax EG-2931 gastroscope
Other names: Pentax EC2931 gastroscope (Pentax, Tokyo, Japan)
Time frame: Seven months
Time frame: Seven months
Shandong University
Other
Comparison of Confocal Laser Endomicroscopy With Standard Endoscopy for the Detection and Evaluation of Gastric Intestinal Metaplasia in a High Risk Population: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06585553
Intestinal Metaplasia
Jinan, Shandong, China
View Trial DetailsNCT06282484
Digestive System Diseases, Digestive System Neoplasms
Xi'an, Shaanxi, China
View Trial DetailsNCT06269380
Gastritis Chronic, Gastritis H Pylori
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT02691637
Atrophic Gastritis, Digestive System Diseases
Seongnam-si, Gyeonggi-do, South Korea
View Trial Details